Preoperative contrast-enhanced ultrasound combined with intra-lymph node methylene blue injection for sentinel lymph node identification: a minimally invasive sentinel lymph node biopsy tracing approach. (2025)

Peer-Reviewed Study · Liu Y, Wu J, Zhang W, Wang T, Wu S, Zhou H, Zhou Y, Liu Y · August 21, 2025

Liu Y et al., 2025-08-21: Prospective randomized single-institution study combining preoperative contrast-enhanced ultrasound with intralymph-node methylene blue injection and intracutaneous indocyanine green for sentinel node identification in early breast cancer.

All patients from a single institution were prospectively randomized into two groups

Liu Y et al., 2025-08-21: Prospective randomized single-institution study combining preoperative contrast-enhanced ultrasound with intralymph-node methylene blue injection and intracutaneous indocyanine green for sentinel node identification in early breast cancer. C7. Study type: prospective randomized trial (single institution); Affiliated Hospital of Southwest Jiaotong University, China. N not stated in the abstract text captured. Methylene blue injected into the lymph node, ICG intracutaneously; doses not stated in the abstract. Funder/conflicts not stated. Reports precise SLN identification and metastasis prediction, minimizing unnecessary non-SLN resection. Eur Radiol 2026;36:863-873. Study type: randomized trial.